Zining Wang
State Key Laboratory Of Oncology In South China
Guangzhou, China
Guangzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
An mRNA Tumor Nanovaccine Expressing Tumor Antigen Fused With Angiotensin II Facilitates Type 1 Conventional Dendritic Cell-Mediated Anti-Tumor Immunity.
Journal: Small (Weinheim an der Bergstrasse, Germany)
Published: November 01, 2025
A STING signaling relay from tumor cells to macrophages mediates the improved efficacy of combination chemotherapy in pancreatic cancer.
Journal: Journal of biomedical science
Published: August 19, 2025
The microbial metabolite I3A inhibits ferroptosis and the effectiveness of redox-based cancer therapy.
Journal: The Journal of biological chemistry
Published: August 14, 2025
RAC2 inhibition enhances tumor sensitivity to NK cell-mediated cytotoxicity.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
A STING agonist potentiates C1 lipidoid-based mRNA cancer vaccine through promoting TNF-α secretion in vivo.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 11, 2025
CBX2 suppresses interferon signaling to diminish tumor immunogenicity via a noncanonical corepressor complex.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2025
Tryptophan Metabolite Indole-3-Aldehyde Induces AhR and c-MYC Degradation to Promote Tumor Immunogenicity.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 12, 2024
Pyrithione zinc alters mismatch repair to trigger tumor immunogenicity.
Journal: Oncogene
Published: July 24, 2024
Endothelial STING-JAK1 interaction promotes tumor vasculature normalization and antitumor immunity.
Journal: The Journal of clinical investigation
Published: February 26, 2024
Cancer cell-intrinsic biosynthesis of itaconate promotes tumor immunogenicity.
Journal: The EMBO journal
Published: January 30, 2024
Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression.
Journal: Cellular oncology (Dordrecht, Netherlands)
Published: January 07, 2024
Last Updated: 09/26/2026